Evaluation of short-term safety of COVID-19 vaccines in patients with multiple sclerosis from Latin America

BACKGROUND: To date, there are no data available on the safety of COVID-19 vaccines in Latin American patients with Multiple Sclerosis (MS). OBJECTIVE: Characterize safety of COVID-19 vaccines in Latin American (LATAM) patients with Multiple Sclerosis (pwMS). METHODS: A cross-sectional study between...

Descripción completa

Detalles Bibliográficos
Autores principales: Alonso, Ricardo, Chertcoff, Aníbal, Leguizamón, Felisa del V, Galleguillos Goiry, Lorna, Eizaguirre, Maria B, Rodríguez, Roberto, Sosa, Marta, Carballido, Susana, Cruchet, Verónica, de Jong-Martis, Agnes, Giachello, Susana, Henestroza, Paula, Ferrandina, Flavia, Bauer, Johana, Carrá, Adriana, Silva, Berenice A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637726/
https://www.ncbi.nlm.nih.gov/pubmed/34868630
http://dx.doi.org/10.1177/20552173211061543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637726/
https://www.ncbi.nlm.nih.gov/pubmed/34868630
http://dx.doi.org/10.1177/20552173211061543

Ejemplares similares